Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.

Women with PCOS often experience skin issues like excess hair, acne, and hair loss.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Women with low SHBG levels and a high 3a-diol G to SHBG ratio are likely to experience female pattern baldness, possibly due to a slight excess of androgens affecting sensitive hair bulbs.

Hormonal status significantly affects women's skin health throughout their lives.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Women with more 3α,17β-androstanediol glucuronide compared to sex hormone binding globulin are more likely to have female pattern baldness.

Nuclear AR levels give better insight into hormone effects in skin conditions.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Women with PCOS often feel anxious and distressed about their appearance, especially in social situations.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Certain gene changes and hormone levels are linked to female hair loss.

12.5% of women with PCOS experience moderate hair loss, highlighting the need for early detection and management.

Acne severity is not related to the type or severity of androgenetic alopecia.

Acne in PCOS can be managed with specific treatment strategies.

Polycystic ovary syndrome (PCOS) affects about 10% of women, is often linked to obesity and family history, and can cause irregular periods, fertility issues, and other symptoms. It's usually managed with lifestyle changes, weight loss, and medication.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

The document discusses how to diagnose and treat conditions like acne, excessive hair growth, and female pattern hair loss related to hormone imbalances.

Women with keloid scars often have acne and hair loss, especially those with "true" keloids, indicating a possible hormonal imbalance.